These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7929199)

  • 1. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II.
    Kao J; Houck K; Fan Y; Haehnel I; Libutti SK; Kayton ML; Grikscheit T; Chabot J; Nowygrod R; Greenberg S
    J Biol Chem; 1994 Oct; 269(40):25106-19. PubMed ID: 7929199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response.
    Kao J; Fan YG; Haehnel I; Brett J; Greenberg S; Clauss M; Kayton M; Houck K; Kisiel W; Seljelid R
    J Biol Chem; 1994 Apr; 269(13):9774-82. PubMed ID: 7545917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms.
    Kao J; Ryan J; Brett G; Chen J; Shen H; Fan YG; Godman G; Familletti PC; Wang F; Pan YC
    J Biol Chem; 1992 Oct; 267(28):20239-47. PubMed ID: 1400342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel tumor-derived mediator that sensitizes cytokine-resistant tumors to tumor necrosis factor.
    Marvin MR; Libutti SK; Kayton M; Kao J; Hayward J; Grikscheit T; Fan Y; Brett J; Weinberg A; Nowygrod R; LoGerfo P; Feind C; Hansen KS; Schwartz M; Stern D; Chabot J
    J Surg Res; 1996 Jun; 63(1):248-55. PubMed ID: 8661206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
    Berger AC; Alexander HR; Wu PC; Tang G; Gnant MF; Mixon A; Turner ES; Libutti SK
    Cytokine; 2000 Jul; 12(7):992-1000. PubMed ID: 10880244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature.
    Kayton ML; Libutti SK
    Curr Opin Investig Drugs; 2001 Jan; 2(1):136-8. PubMed ID: 11527006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic damage of tumor vessels with ultra low-dose endothelial-monocyte activating polypeptide-II and neovasculature-targeted tumor necrosis factor-alpha.
    Crippa L; Gasparri A; Sacchi A; Ferrero E; Curnis F; Corti A
    Cancer Res; 2008 Feb; 68(4):1154-61. PubMed ID: 18281491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
    Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
    Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
    Berger AC; Alexander HR; Tang G; Wu PS; Hewitt SM; Turner E; Kruger E; Figg WD; Grove A; Kohn E; Stern D; Libutti SK
    Microvasc Res; 2000 Jul; 60(1):70-80. PubMed ID: 10873516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism.
    Murray JC; Symonds P; Ward W; Huggins M; Tiga A; Rice K; Heng YM; Todd I; Robins RA
    J Immunol; 2004 Jan; 172(1):274-81. PubMed ID: 14688335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial-monocyte-activating polypeptide II.
    Tas MP; Murray JC
    Int J Biochem Cell Biol; 1996 Aug; 28(8):837-41. PubMed ID: 8811833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells.
    Schwarz MA; Kandel J; Brett J; Li J; Hayward J; Schwarz RE; Chappey O; Wautier JL; Chabot J; Lo Gerfo P; Stern D
    J Exp Med; 1999 Aug; 190(3):341-54. PubMed ID: 10430623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
    Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
    J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis.
    Murray JC; Heng YM; Symonds P; Rice K; Ward W; Huggins M; Todd I; Robins RA
    J Leukoc Biol; 2004 May; 75(5):772-6. PubMed ID: 14982944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial monocyte-activating polypeptide II causes NOS-dependent pulmonary artery vasodilation: a novel effect for a proinflammatory cytokine.
    Tsai BM; Wang M; Clauss M; Sun P; Meldrum DR
    Am J Physiol Regul Integr Comp Physiol; 2004 Oct; 287(4):R767-71. PubMed ID: 15155281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis induced by a corneal-endothelium-derived cytokine.
    Liu SH; Gottsch JD
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3152-9. PubMed ID: 10586937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of endothelial monocyte activating polypeptide II in tumor necrosis factor-alpha-based anti-cancer therapy.
    Lans TE; Van Horssen R; Eggermont AM; Ten Hagen TL
    Anticancer Res; 2004; 24(4):2243-8. PubMed ID: 15330168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and expression of human endothelial-monocyte-activating polypeptide 2 (EMAP-2) and identification of its putative precursor.
    Tas MP; Houghton J; Jakobsen AM; Tolmachova T; Carmichael J; Murray JC
    Cytokine; 1997 Aug; 9(8):535-9. PubMed ID: 9245479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of endothelial-monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells.
    Schluesener HJ; Seid K; Zhao Y; Meyermann R
    Glia; 1997 Aug; 20(4):365-72. PubMed ID: 9262239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte-activating polypeptide II in soft tissue sarcoma.
    Lans TE; ten Hagen TL; van Horssen R; Wu PC; van Tiel ST; Libutti SK; Alexander HR; Eggermont AM
    Ann Surg Oncol; 2002 Oct; 9(8):812-9. PubMed ID: 12374666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.